Post Chikungunya Arthritis: A Real Diagnostic and Therapeutic Challenge

Abstract

Ocean. Karachi, a city in Pakistan, suffered a similar massive outbreak in November 2016 in which more than 30,000 people were affected by the virus. Clinically, it initially presents with sudden onset fever, polyarthralgia, rash, headache, nausea, fatigue and myalgia. The disease itself is self-limiting, joint pain can 5 be persistent for months and even years in some cases. At present there are no vaccines or anti-viral drugs for the prevention and treatment of CHIK viral infection. However, multiple drugs are under trial. Treatment remains symptomatic with analgesics, anti-pyretic and 6 NSAIDs.

COVID-19: An Emerging Culprit of Inflammatory Arthritis

“…Chikungunya virus is also commonly associated with postviral arthralgia. A similar phenomenon of postviral inflammatory arthritis was reported by Ghauri et al after a Chikungunya virus epidemic broke out in Pakistan in 2017 [ 21 ]. A large cross-sectional study was carried out by Dr. Chang on patients with chikungunya who developed inflammatory arthritis, but the synovial fluid did not reveal the presence of the virus.…”